These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review. Wirdefeldt K, Odin P, Nyholm D. CNS Drugs; 2016 May; 30(5):381-404. PubMed ID: 27138916 [Abstract] [Full Text] [Related]
3. Cost-utility analysis of levodopa carbidopa intestinal gel (Duodopa) in the treatment of advanced Parkinson's disease in patients in Scotland and Wales. Kalabina S, Belsey J, Pivonka D, Mohamed B, Thomas C, Paterson B. J Med Econ; 2019 Mar; 22(3):215-225. PubMed ID: 30484353 [Abstract] [Full Text] [Related]
5. Use of advanced therapies for Parkinson's disease in Norway. Ezat B, Pihlstrøm L, Aasly J, Tysnes OB, Egge A, Dietrichs E. Tidsskr Nor Laegeforen; 2017 May; 137(9):619-623. PubMed ID: 28468476 [Abstract] [Full Text] [Related]
6. [Treatment possibilities in advanced Parkinson's disease]. Takáts A, Nagy H, Radics P, Tóth A, Tamás G. Ideggyogy Sz; 2013 Nov 30; 66(11-12):365-71. PubMed ID: 24555235 [Abstract] [Full Text] [Related]
11. Duodenal Levodopa Infusion for Long-Term Deep Brain Stimulation-Refractory Symptoms in Advanced Parkinson Disease. Regidor I, Benita V, Del Álamo de Pedro M, Ley L, Martinez Castrillo JC. Clin Neuropharmacol; 2017 Nov 30; 40(3):103-107. PubMed ID: 28452905 [Abstract] [Full Text] [Related]
13. The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on 'Off'-time in Patients with Advanced Parkinson's Disease: A Systematic Review. Antonini A, Odin P, Pahwa R, Aldred J, Alobaidi A, Jalundhwala YJ, Kukreja P, Bergmann L, Inguva S, Bao Y, Chaudhuri KR. Adv Ther; 2021 Jun 30; 38(6):2854-2890. PubMed ID: 34018146 [Abstract] [Full Text] [Related]
14. Current Practices for Outpatient Initiation of Levodopa-Carbidopa Intestinal Gel for Management of Advanced Parkinson's Disease in the United States. Amjad F, Bhatti D, Davis TL, Oguh O, Pahwa R, Kukreja P, Zamudio J, Metman LV. Adv Ther; 2019 Sep 30; 36(9):2233-2246. PubMed ID: 31278691 [Abstract] [Full Text] [Related]
17. [Experience with levodopa/carbidopa intestinal gel in the treatment of advanced Parkinson's disease in Hungary]. Nagy H, Takáts A, Tóth A, Bereczki D, Klivényi P, Dézsi L, Dibó G, Vécsei L, Kovács N, Aschermann Z, Komoly S, Varannai L, Zemlényi G, Valikovics A. Ideggyogy Sz; 2014 Nov 30; 67(11-12):385-9. PubMed ID: 25720240 [Abstract] [Full Text] [Related]
19. Workforce participation and activities in Parkinson's disease patients receiving device-aided therapy. Sahlström T, Eklund M, Timpka J, Henriksen T, Nyholm D, Odin P. Acta Neurol Scand; 2018 Jul 30; 138(1):78-84. PubMed ID: 29569237 [Abstract] [Full Text] [Related]
20. Burden of non-motor symptoms in Parkinson's disease patients predicts improvement in quality of life during treatment with levodopa-carbidopa intestinal gel. Ray Chaudhuri K, Antonini A, Robieson WZ, Sanchez-Soliño O, Bergmann L, Poewe W, GLORIA study co-investigators. Eur J Neurol; 2019 Apr 30; 26(4):581-e43. PubMed ID: 30353942 [Abstract] [Full Text] [Related] Page: [Next] [New Search]